Search results for "MUCOSA"

showing 10 items of 1066 documents

Modulation of MMP-2 and MMP-9 in Churg-Strauss syndrome respiratory mucosa: potential monitoring parameters.

2014

Churg-Strauss (CSS) syndrome is rare and of unknown etiology. It is associated with vasculitis, blood eosinophilia and granulomatosis, and affects multiple organs and systems at various stages of the disease. Specific diagnostic and monitoring tests are not yet available. This study aims to assess the changes in MMP-2 and MMP-9 along with the histopathological alterations in two cases of CSS, as possible potential diagnostic and monitoring criteria. Two adult male patients were diagnosed with CSS in the otorhinolaryngology clinic in the University of Palermo, based on multiple clinical and histopathologic criteria. Biopsies of respiratory mucosa were taken after the consent of the patients…

Settore BIO/17 - IstologiaRespiratory MucosaAdultMalemedicine.medical_specialtyPathologyAngiogenesisBiopsyImmunologyRespiratory MucosaChurg-Strauss SyndromePredictive Value of TestsmedicineImmunology and AllergyEosinophiliaHumansRNA MessengerPharmacologyMMPbusiness.industrymedicine.diseaseImmunohistochemistryUp-RegulationReal-time polymerase chain reactionMatrix Metalloproteinase 9Case-Control StudiesEtiologyImmunohistochemistryMatrix Metalloproteinase 2Histopathologymedicine.symptomVasculitisbusinessBiomarkersInternational journal of immunopathology and pharmacology
researchProduct

Transbuccal delivery of l-dopa methyl ester: ex vivo permeation studies

2012

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoL-DOPA methyl ester BUCCAL DELIVERY Parkinson Disease Porcine Buccal Mucosa Ex vivo permeation model
researchProduct

Optimization of local delivery of antifungal agents in the oral cavity by a new formulation

2012

In recent years, with the increased use of antibiotics and immunosuppres-sive agents, there was an increased incidence of oral mycosis and Candida albicans is the most common etiologic agent in oropharyngeal candidiasis, especially in patients with HIV. The aim of this work is to develop a new dosage form containing miconazole (MN) to be topically applied on oral mucosa, allowing for a massive penetration of the drug in the tissue. The vehicle for the drug delivery was lipid microparticles incorporated in a hydrophilic gel. The lipospheres were obtained by hot melt encapsulation method using as matrix ingredients a mixtures of esters of fatty acids with higher fatty alcohols, having low mel…

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoOral mucosaAntifungalLipid microspheres
researchProduct

Novel Drug Delivery System for Treatment-Resistant Schizophrenia

2021

Settore CHIM/09 - Farmaceutico Tecnologico Applicativotreatment-resistant schizophrenia clozapine oral transmucosal delivery solid dosage form unidirectional delivery sustained release profile
researchProduct

Recognizing the Emergent and Submerged Iceberg of the Celiac Disease: ITAMA Project-Global Strategy Protocol.

2022

Coeliac disease (CD) is frequently underdiagnosed with a consequent heavy burden in terms of morbidity and health care costs. Diagnosis of CD is based on the evaluation of symptoms and anti-transglutaminase antibodies IgA (TGA-IgA) levels, with values above a tenfold increase being the basis of the biopsy-free diagnostic approach suggested by present guidelines. This study showcased the largest screening project for CD carried out to date in school children (n=20,000) aimed at assessing the diagnostic accuracy of minimally invasive finger prick point-of-care tests (POCT) which, combined with conventional celiac serology and the aid of an artificial intelligence-based system, may eliminate t…

Settore INF/01 - Informaticaintestinal biopsypoint-of-care testanti-transglutaminaseguidelinesnegative predictive valueartificial intelligenceESPGHANmucosal depositsPediatricscoeliac diseaseSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Pediatric reports
researchProduct

Patients' Acceptability of Different Fentanyl Products for Breakthrough Cancer Pain

2014

OTFC (6) 1.7 (0.5) 1.5 (0.5) 2.0 (0.6) 1.5 (0.8) 1.5 (0.5) 33.1 (43.5) FBT (19) 2.0 (0.6) 2.0 (0.7) 1.8 (0.7) 1.8 (0.8) 1.9 (0.7) 15.9 (7.3) SLF (37) 2.1 (0.5) 2.2 (0.4) 1.8 (0.4) 2.0 (0.6) 2.1 (0.5) 16.7 (12.5) INFS (7) 2.1 (0.4) 2.1 (0.4) 2.0 (0.6) 2.0 (0.8) 2.0 (0.8) 15.7 (13.7) PFEN (11) 2.4 (0.5) 2.2 (0.4) 1.8 (0.4) 1.9 (0.7) 2.1 (0.5) 15.0 (13.7) P 0.120 0.043* 0.870 0.595 0.178 0.015x *,x Oral transmucosal fentanyl was significantly considered to be more problematic.

Settore MED/06 - Oncologia Medicabusiness.industryBreakthrough PainBreakthrough PainPatient Acceptance of Health CareSettore MED/42 - Igiene Generale E ApplicatafentanylFentanylbreakthrough cancer painBTPOncologyNeoplasmsAnesthesiaAdministration MucosalHumansMedicineRadiology Nuclear Medicine and imagingpatient's preferencefentanyl; breakthrough cancer pain; BTP; patient's preferencebusinessCancer painmedicine.drugClinical Oncology
researchProduct

From gut microflora imbalance to mycobacteria infection: is there a relationship with chronic intestinal inflammatory diseases?

2011

The gut of a healthy adult harbours a myriad of different microbial species. It is estimated that approximately 10 14 are present in total bacterial colony forming units (CFU). Each colony colonizes a specific intestinal tract. In healthy adult, the main control of intestinal bacterial colonization occurs through gastric acidity but also other factors can influence the intestinal microenvironment such as pH, temperature, competition among different bacterial strains, peristalsis, drugs, radiotherapy and much more. Impaired microbial homeostasis leads to an alteration of the permeability of tissue, together with the activation of the intestinal immune system MALT (mucosal associated lymphoid…

Settore MED/07 - Microbiologia E Microbiologia ClinicaProbioticsMycobacterium Infections NontuberculousNontuberculous MycobacteriaInflammatory Bowel DiseasesSettore MED/18 - Chirurgia GeneraleTreatment OutcomeCrohn DiseaseRisk FactorsChronic DiseaseHumansColitis Ulcerativeintestinal microflora imbalance intestinal immune system chronic intestinal diseases mycobacteria probioticsIntestinal MucosaAnnali italiani di chirurgia
researchProduct

Searching for wheat plants with low toxicity in celiac disease: Between direct toxicity and immunologic activation.

2009

Abstract Background Natural or induced variations in the noxiousness of gluten proteins for celiac disease (CD) patients are currently being investigated for their potential in breeding wheat crops with reduced toxicity. Aims We evaluated the bread wheat line C173 for its effects on the in vitro -grown duodenal mucosa of CD patients. Methods In vitro -grown duodenal mucosa biopsies of 19 CD patients on a gluten-free diet were exposed to peptic/tryptic-digested prolamins from bread wheat line C173 lacking gliadin–glutenin subunits, analyzed for morphology, cytokine and anti-tTG antibody production, and compared with mucosa biopsies exposed to prolamins from wild-type cv. San Pastore. Results…

Settore MED/09 - Medicina InternaEnterocytemedicine.medical_treatmentAntibodiesTissue Culture TechniquesImmunologic activationInterferon-gammamedicineHumansIntestinal MucosaProlaminCommon wheatTriticumHepatologybiologyGastroenterologyfood and beveragestoxicityimmunologic activation.Interleukin-10Cytokinemedicine.anatomical_structureAnti-transglutaminase antibodiesImmunologyToxicitybiology.proteinInterleukin-2AntibodyGene Deletionwheat plantceliac diseaseProlamins
researchProduct

Rectal mucosa inflammation in non-celiac wheat sensitivity: comparison with duodenal histology.

2018

Background and Aims: In recent years an increasing number of studies on Non-Celiac Gluten/Wheat Sensitivity (NCG/WS) have been published but no markers of this condition have as yet been found. Although the NCG/WS clinical presentation often overlaps with IBS, no previous study evacuate colon or rectal histology in NCG/WS patients. Patients and Methods: We performed a prospective study on 78 patients (66 females, 12 males, mean age 36. 4 years) diagnosed with NCG/WS by double-blind wheat challenge, presenting at two tertiary care centers in Italy from January 2015 through September 2016. Data were also collected from 55 control patients either with celiac disease (CD) or with self-reported …

Settore MED/09 - Medicina InternaRectal mucosainflammationnon-celiac wheat sensitivityduodenal mucosa
researchProduct

Gluten Induces Subtle Histological Changes in Duodenal Mucosa of Patients with Non-Coeliac Gluten Sensitivity : A Multicentre Study

2022

Background: Histological changes induced by gluten in the duodenal mucosa of patients with non-coeliac gluten sensitivity (NCGS) are poorly defined. \ud \ud \ud \ud Objectives: To evaluate the structural and inflammatory features of NCGS compared to controls and coeliac disease (CeD) with milder enteropathy (Marsh I-II). \ud \ud \ud \ud Methods: Well-oriented biopsies of 262 control cases with normal gastroscopy and histologic findings, 261 CeD, and 175 NCGS biopsies from 9 contributing countries were examined. Villus height (VH, in μm), crypt depth (CrD, in μm), villus-to-crypt ratios (VCR), IELs (intraepithelial lymphocytes/100 enterocytes), and other relevant histological, serologic, and…

Settore MED/12 - GastroenterologiaNutrition and DieteticsSettore MED/09 - Medicina InternaGlutensDuodenumnon-coeliac gluten sensitivityBiopsySettore MED/08 - Anatomia Patologica3121 Internal medicinedigestive systemhistologynormal mucosaCeliac DiseaseDiet Gluten-FreeHumansIntestinal Mucosanon-coeliac gluten sensitivity; histology; normal mucosa; coeliac diseasecoeliac disease; histology; non-coeliac gluten sensitivity; normal mucosacoeliac diseaseFood Science
researchProduct